ValiRx Regulatory News (VAL)

27 Feb 2009 07:00



ValiRx plc

(the "Company")

Total Voting Rights

For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, following the reorganisation of the Company's share capital announced on 13 February 2009, the total number of ordinary shares of 1p each in the capital of the Company in issue as at the date of this notice is 58,378,365 with each share carrying the right to one vote.

There are no shares held in treasury.

Therefore, the total number of voting rights in the Company remains unchanged at 58,378,365.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

For more information, please contact: